MedPath

Epidemiology of Long Covid - a cross-sectional questionnaire study (EPILOC1)

Conditions
U09.9
Post COVID-19 condition, unspecified
Registration Number
DRKS00027012
Lead Sponsor
niversitätsklinikum Freiburg
Brief Summary

Objectives: To describe symptoms and symptom clusters of postcovid syndrome six to 12 months after acute infection, describe risk factors, and examine the association of symptom clusters with general health and working capacity. Design: Population-based, cross-sectional study Setting: Adults aged 18-65 years with confirmed SARS-CoV-2 infection between October 2020 and March 2021 notified to health authorities in four geographically defined regions in southern Germany. Participants: 50457 patients were invited to participate in the study, of whom 12053 (24%) responded and 11710 (58.8% (n=6881) female; mean age 44.1 years; 3.6% (412/11602) previously admitted with covid-19; mean follow-up time 8.5 months) could be included in the analyses. Main outcome measures: Symptom frequencies (six to 12 months after versus before acute infection), symptom severity and clustering, risk factors, and associations with general health recovery and working capacity. Results: The symptom clusters fatigue (37.2% (4213/11312), 95% confidence interval 36.4% to 38.1%) and neurocognitive impairment (31.3% (3561/11361), 30.5% to 32.2%) contributed most to reduced health recovery and working capacity, but chest symptoms, anxiety/depression, headache/dizziness, and pain syndromes were also prevalent and relevant for working capacity, with some differences according to sex and age. Considering new symptoms with at least moderate impairment of daily life and =80% recovered general health or working capacity, the overall estimate for post-covid syndrome was 28.5% (3289/11536, 27.7% to 29.3%) among participants or at least 6.5% (3289/50457) in the infected adult population (assuming that all non-responders had completely recovered). The true value is likely to be between these estimates. Conclusions: Despite the limitation of a low response rate and possible selection and recall biases, this study suggests a considerable burden of self-reported post-acute symptom clusters and possible sequelae, notably fatigue and neurocognitive impairment, six to 12 months after acute SARS-CoV-2 infection, even among young and middle aged adults after mild infection, with a substantial impact on general health and working capacity.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
11710
Inclusion Criteria

SARS-CoV-2 infection between 1.10.2020 through 01.04.2021
- 18 to 65 years old
- infection notified to public health department in selected counties in the Federal State of Baden-Württemberg

Exclusion Criteria

- Age <18 or >65 years old
- unconfirmed acute SARS-CoV-2 infection (clinical diagnosis or antigen test w/o PCR confirmation)

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Persistent health problems 6 to 12 months after acute SARS-CoV-2 infection
Secondary Outcome Measures
NameTimeMethod
reduced workabality since acute SARS-CoV-2 infection
© Copyright 2025. All Rights Reserved by MedPath